Influence of clove oil and eugenol on muscle contraction of silkworm (<i>Bombyx mori</i>)

DOI Web Site PubMed 参考文献29件 オープンアクセス
  • Kheawfu Kantaporn
    Nanoscience and Nanotechnology Program, The Graduate School, Chiang Mai University
  • Pikulkaew Surachai
    Department of Food Animal Clinic, Faculty of Veterinary Medicine, Chiang Mai University
  • Hamamoto Hiroshi
    Laboratory of Microbiology, Graduate School of Pharmaceutical Sciences, The University of Tokyo Teikyo University Institute of Medical Mycology
  • Sekimizu Kazuhisa
    Laboratory of Microbiology, Graduate School of Pharmaceutical Sciences, The University of Tokyo Teikyo University Institute of Medical Mycology
  • Okonogi Siriporn
    Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University Research Center of Pharmaceutical Nanotechnology, Chiang Mai University

抄録

<p>Clove oil is used in fish anesthesia and expected to have a mechanism via glutamic receptor. The present study explores the activities of clove oil and its major compound, eugenol, in comparison with L-glutamic acid on glutamic receptor of silkworm muscle and fish anesthesia. It was found that clove oil and eugenol had similar effects to L-glutamic acid on inhibition of silkworm muscle contraction after treated with D-glutamic acid and kainic acid. Anesthetic activity of the test samples was investigated in goldfish. The results demonstrated that L-glutamic acid at 20 and 40 mM could induce the fish to stage 3 of anesthesia that the fish exhibited total loss of equilibrium and muscle tone, whereas clove oil and eugenol at 60 ppm could induce the fish to stage 4 of anesthesia that the reflex activity of the fish was lost. These results suggest that clove oil and eugenol have similar functional activities and mechanism to L-glutamic acid on muscle contraction and fish anesthesia.</p>

収録刊行物

  • Drug Discoveries & Therapeutics

    Drug Discoveries & Therapeutics 11 (2), 64-69, 2017

    特定非営利活動法人 バイオ&ソーシャル・サイエンス推進国際研究交流会

参考文献 (29)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ